Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iressa in recurrent/metastatic esophageal cancer
NCT00268346Phase 2Completed
- Sponsor
- Case Comprehensive Cancer Center
- Start
- Oct 2005
- Primary completion
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gefitinib in esophageal cancer, gastroesophageal junction cancer, sponsored by Case Comprehensive Cancer Center. Started Oct 2005; status: completed.
02
Drugs
03
Conditions
esophageal cancergastroesophageal junction cancer
Beyond the preview
Go deeper on NCT00268346.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00268346.